Compare RLAY & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLAY | UPBD |
|---|---|---|
| Founded | 2015 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2020 | 1995 |
| Metric | RLAY | UPBD |
|---|---|---|
| Price | $7.69 | $18.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $16.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 2.1M | 742.9K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 8.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.45 |
| Revenue | $8,355,000.00 | ★ $4,577,844,000.00 |
| Revenue This Year | $20.47 | $10.45 |
| Revenue Next Year | N/A | $8.03 |
| P/E Ratio | ★ N/A | $12.99 |
| Revenue Growth | N/A | ★ 7.48 |
| 52 Week Low | $1.78 | $15.82 |
| 52 Week High | $8.36 | $34.86 |
| Indicator | RLAY | UPBD |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 50.76 |
| Support Level | $7.23 | $17.49 |
| Resistance Level | $8.36 | $19.49 |
| Average True Range (ATR) | 0.51 | 0.72 |
| MACD | 0.05 | 0.38 |
| Stochastic Oscillator | 69.18 | 80.93 |
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.